baber/WOPTO huggingface dataset:
Patent FI-833277-A0 (FI)
Inventor: HANNUKAINEN HANNU
IPC: A01B63/112
Filed: 1983-09-13
Abstract: A tubular flexural bar (15), consisting of magnetic material, contains an iron core (23) of magnetically soft material, on opposing limbs of which are wound a pair of exciting coils (27,28). The shaped corners of the iron core (23) make good magnetic contact with the inner surface of the flexural bar (15). Magnetic flux is induced by the coil excitation in three parts, the first two producing flux which passes through two paths in the flexural bar, whilst a third flux circulates around the core and through the air gap (25) to be detected by a Hall element (26). When the flexual bar (15) is loaded, its reluctance changes and the first fluxes become unequal, changing the gap flux with a resulting signal from the element (26) being related to the distorting force applied to the flexural bar (15).
Patent FI-834694-A0 (FI)
Inventor: SPENGLER WALTER
IPC: B41F9/06
Filed: 1983-12-20
Abstract: 1. Printing device with additional electrostatic field for assisting the colour transfer from a printing cylinder (2) onto a dielectric substrate web (3) in a printing gap (6) formed between he printing cylinder surface and an electrostatically chargeable outer sheating layer (5) of a hollow-cylindrical impression roller (4), with the outer sheathing layer (5), for the electrostatic charging of at least one section of the outer sheathing layer (5) of the impression roller (4), which selection is in each case moved through the printing gap, being loaded with a high voltage which is fed into the inner space (8) of the impression roller (4) via a highvoltage lead (9) guided through at least one of the endface bearing arrangements (10) fo the impression roller (4), and with conducting means (13) which are firmly insulated against high voltage and are guided through the hollow-cylindrical wall construction of the impression roller (4) being available between the inner space of the impression roller (4) and its electrostatically chargeable outer sheathing layer (5), which conducting means (13) are connected at least in section to the outer sheathing layer (5), characterized by an inductor device (7) for loading the outer sheathing layer (5), which inductor device (7) is provided in the inner space (8) of the hollow-cylindrical impression roller (4).
Patent FI-840224-A0 (FI)
Inventor: ROSSY PHILLIP A
IPC: C07D237/26
Filed: 1984-01-19
Abstract: Novel 6-(acylaminaryl)-3(2H)-pyridazinones of the formula    <IMAGE> (I)  where R1, R2, R3, R4, A and B have the meanings given in the description, and their preparation are described. The compounds have thrombocyte aggregation-inhibiting activity.
Patent FI-860355-A0 (FI)
Inventor: STOBBE ANATOLI
IPC: G06F19/00
Filed: 1986-01-24
Abstract: PCT No. PCT/DE85/00176 Sec. 371 Date Jan. 24, 1986 Sec. 102(e) Date Jan. 24, 1986 PCT Filed May 21, 1985 PCT Pub. No. WO85/05712 PCT Pub. Date Dec. 19, 1985.A control system is provided having stationary check points which are contactlessly read by a data collector and verified. The data so read can be stored and transmitted by a transmitter to a central unit, where the data so received are centrally evaluated. Together with the data of the check point being read, the time at which the respective check point is read is transmitted to the central unit as well. If all data are received by the central unit, it transmits back a verification entry, and the data are subsequently stored in a memory together with such verification entry. If no verification entry is received, the data are automatically and continually retransmitted to the central unit until the verification entry is received by the receiver in the data collector. In addition, the data collector has a random generator capable of establishing which individual check points are to be successively called on by the security guard. Each check point is to be called on within a time range and, if such time limit is exceeded, an emergency call is automatically transmitted to the central unit.
Patent FI-900574-A0 (FI)
Inventor: BJOERNBERG STEN
IPC: A61F13/53
Filed: 1990-02-06
Abstract: An absorbent pad such as an incontinence pad comprises a liquid-impervious back sheet with spaced islands of absorbent material thereon. A liquid-pervious cover sheet has pockets formed therein, in which the islands of absorbent material are disposed. The cover sheet is secured, either adhesively or by heat sealing, directly to the impervious sheet along lines that separate the islands of absorbent material and the pockets that contain them. The pad is formed by applying a strip of cover sheet material to a rotating multi-perforate drum and forming the pockets in the cover sheet material either mechanically, or by drawing hot air inwardly through the holes in the drum in the case of a heat-deformable material such as polypropylene fibers. The drum then rotates past a pocket-filling station, where absorbent material such as cellulose fluff is drawn into the pockets by vacuum applied internally of the drum. The cover sheet is then applied to the composite of cover sheet and absorbent material, and is firmly bonded to lines of cover sheet material that are free from absorbent material between the pockets, overlying the bridges that separate the holes through the drum. The composite is then removed from the drum and cut to size.
Patent FI-902000-A0 (FI)
Inventor: KIVIRANTA SEPPO
IPC: D21F1/32
Filed: 1990-04-20
Abstract: The invention concerns an equipment in a paper  machine for collecting the mist that is produced  in the spraying of high-pressure water employed  in the washing of a wire of a paper machine out  of contact with the wire (H). The equipment  comprises such an inlet duct (12) extending a  cross the wire width whose central axis (X) is at  an oblique angle ( alpha ) in relation to the direction  of running of the wire (H). The equipment fur  ther comprises a jet guide (13) in connection  with the inlet opening (12a) of the inlet duct  (12), said jet guide being a plate-shaped part  connected to the frame (11) by means of adjust  ing members (14) and operating as an air closure  and as a regulator of suction capacity. The  position of the jet guide (13) can be adjusted  relative the surface plane of the wire (H) by  means of the adjusting members (14). <IMAGE>
Patent FI-902237-A0 (FI)
Inventor: BIERI FRITZ
IPC: A45C11/04
Filed: 1990-05-04
Abstract: PCT No. PCT/CH89/00159 Sec. 371 Date May 7, 1990 Sec. 102(e) Date May 7, 1990 PCT Filed Sep. 1, 1989 PCT Pub. No. WO90/02535 PCT Pub. Date Mar. 22, 1990.The device is useful for detecting deposts on the surface of contact lenses and changes in the material of the contact lenses. It consists of an optically transparent rod-shaped body (1) with two end faces. One end face (2), in which the contact lens is placed, has a smooth surface and can be spherical, aspherical or toroidal, with a curvature in the range of that of the contact lens to be examined. The other end face (3) has a smooth or mat surface and can be flat, convex or concave. The rod-shaped body (1) may also be assembled from elements (4, 8, 11). The device is cheap to manufacture and simple for occulists, opticians and wearers of contact lenses to use.
Patent FI-914942-A0 (FI)
Inventor: AMSTUTZ RENE
IPC: C07D/
Filed: 1991-10-18
Abstract: Ergoline derivatives of the formula I <IMAGE> in which R1, R2 and R3 are as defined in the description, their preparation and use as therapeutics.
Patent FI-915570-A0 (FI)
Inventor: VIKMON MARIA
IPC: C07D413/04
Filed: 1991-11-26
Abstract: PCT No. PCT/HU91/00013 Sec. 371 Date Jan. 2, 1992 Sec. 102(e) Date Jan. 2, 1992 PCT Filed Mar. 28, 1991.The invention relates to inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same. The inclusion complex of 3-morpholino-sydnonimine or its salt formed with cyclodextrin derivative is prepared by a) reacting the 3-morpholino-sydnonimine or its salt in an aqueous medium with a cyclodextrin derivative and the complex is isolated from the solution by dehydratation, or b) high energy milling of 3-morpholino-sydnonimine or its salt and a cyclodextrin derivative.
Patent FI-932394-A0 (FI)
Inventor: HEDLUND GUNILLA
IPC: A61F13/49
Filed: 1993-05-26
Abstract: PCT No. PCT/SE91/00802 Sec. 371 Date May 11, 1993 Sec. 102(e) Date May 11, 1993 PCT Filed Nov. 26, 1991 PCT Pub. No. WO92/09253 PCT Pub. Date Jun. 11, 1992.The present invention relates to a casing intended for an absorbent article, such as a disposable diaper, incontinence guard or like article. The casing (1) includes a front-part (5), a rear-part (10) and an intermediate crotch-part (22) made of flexible casing material. According to the invention, an elastic band (14, 15) is provided on each outer edge of the casing sides, at least within the crotch-part of the casing. The elastic band is attached, in a stretched state, to that side of the casing which lies nearest the skin of the user when the absorbent article is worn, by means of a narrow, elongated join. The elastic bands also include parts which extend transversely in relation to respective joins, in a direction from the joins in towards the central part of the casing.
Patent FI-932446-A0 (FI)
Inventor: JOHNSTON J O'NEAL
IPC: C07J71/00
Filed: 1993-05-28
Abstract: The present invention is directed to 2 beta ,19-(methyleneamino)androst-4-ene-3,17-dione which has the formula <IMAGE>  and the corresponding 17 beta -ol which are useful as aromatase inhibitors. The compounds are prepared by the cyclization of an appropriate 19-[N-protected-[(2-methoxyethoxy)methylamino] steroid using titanium tetrachloride followed by, if desired, selective reduction of the 17-ketone.
Patent FI-954024-A0 (FI)
Inventor: NAMUR MARC
IPC: B63H9/00
Filed: 1995-08-28
Abstract: The fixture is for the foot loop straps of surf boards. Fixture rails (6) are spaced apart on the board top in the board body. They contain an insert slot (37), a back cut (36) and a top side positioning groove (39) for insertion of bolt pins (40) with a pivot grip (41). The bolt pins fit rotatably in fixture plates (42) at the ends of the foot loop straps and have a bolt lug formation (44) matching the insert slot of the bores (36) in the fixture rails. By rotation of a bolt pin inserted in the accommodation bore of the fixture rail corresponding to the selected positions of the foot loop strap, the pin enters into engagement with the bolt lug formation with the back cut of the accommodation bore.
Patent FI-974395-A0 (FI)
Inventor: WOZNEY JOHN M
IPC: A61L27/22
Filed: 1997-12-02
Abstract: Methods and compositions are provided for the treatment of defects and disease involving the functional attachment of connective tissue, such as tendon or ligament, to bone. Preferred methods comprise administering a composition containing a bone morphogenetic protein and a suitable carrier. The method results in the regeneration of functional attachment between the connective tissue and bone, such that minimal fibrous or granulation tissue is formed at the interface between the regenerated bone and connective tissue. The method and composition are useful for augmenting tissue grafts in reconstructive surgery. The method and compositions result in closer apposition of bone to the connective tissue at earlier time points and increased strength of fixation at earlier time points.
Patent IL-66289-A0 (IL)
Title: Preparation of analytical element for specific binding assays
IPC: G01N33/52
Filed: 1982-07-09
Abstract: The invention provides an analytical element and a method for preparing an analytical element for evaluation of a liquid sample with respect to a particular analyte by (a) incorporating a carrier with a composition in a liquid, the composition comprising at least one reagent of an analyte-detecting system, under conditions effective to ionize a reagent migration inhibiting substance, which substance is insoluble in said liquid when in its nonionized form and soluble in said liquid when ionized, and drying the carrier; and then (b) incorporating the carrier of (a) with a second composition in a liquid different from that of (a), the composition comprising the remaining reagents of the analyte-detecting system which are reactive with the at least one reagent of (a) and a reagent migration inhibiting substance which is soluble in said liquid when in its nonionized form, which liquid is effective to prevent reaction of the second composition with the at least one reagent of (a) prior to contact of the element with the sample and to prevent the migration inhibiting substance from ionizing prior to contact with the sample, and drying the carrier. Preferably, conditions which ionize the reagent migration inhibiting substance are the use of an aqueous liquid at a pH of at least about 5. Preferably, the reagent migration inhibiting substance is a monoester maleic acid polymer such as a copolymer of methyl vinyl ether and the monomethylester of maleic acid. The liquid of (b) is preferably an organic liquid, such as acetone.
Patent IL-71984-A0 (IL)
Title: Esters of 2-bromo-4-methylimidazole-5-carboxylic acid and their use as herbicides
IPC: C07D233/90
Filed: 1984-05-31
Abstract: A compound having the structural formula <CHEM> wherein R is alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, benzyl or substituted benzyl.
Patent IL-78634-A0 (IL)
Title: 7-substituted bicyclic pyrazolidinones
IPC: C07D/
Filed: 1986-04-28
Abstract: 7-Substituted bicyclic pyrazolidinone compound as antimicrobials and the corresponding intermediates, are discussed or provided. The use of the antimicrobial compounds in pharmaceutical compositions and in methods for treating bacterial infections is set forth. The pyrazolidinone compounds are of the formula 
<CHEM>
 wherein one of R1 and R2 is hydrogen, halo, C1 to C6 alkyl, C1 to C6 substituted alkyl, perfluoro C2 to C4 alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, a heterocyclic ring, nitro or cyano;
 a group of the formula
 -CX3
 wherein X is fluoro, chloro, bromo or iodo; a group of the formula 
<CHEM>
 wherein z is 0, 1 or 2 and R7 is C1 to C6 alkyl, C1 to C6 substituted alkyl, phenyl, substituted phenyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl or a heterocyclic ring;
 a group of the formula
 -COR8
 wherein R8 is hydrogen, C1 to C6 alkyl, C1 to C6 substituted alkyl, perfluoro C2 to C4 alkyl, trihalomethyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, amino, (monosubstituted)amino, or (disubstituted)amino;
 a group of the formula
 -COOR9
 wherein R9 is hydrogen, an organic or inorganic cation, C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, a carboxy-protecting group, or a non-toxic, metabolically-labile, ester-forming group;
 a group of the formula
 -PO3(R10)2
 wherein R10 is hydrogen, an organic or inorganic cation, C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, or substituted phenyl;
 a group of the formula
 -CH2-@ IDENTICAL Q
 wherein -@ IDENTICAL Q is a quarternary ammonium group; or a group of the formula
 -CH2-S-Heterocyclic ring;
 a group of the formula
 -OR11
 wherein R11 is hydrogen, C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl or C1 to C7 acyl;
 or a group of the formula
 -NR12R13
 wherein R12 and R13 are the same or different and are hydrogen C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, C1 to C7 acyl, or a group of the formula;
 @

 ORq
 wherein Rq is C1 to C6 alkyl, C7 to C12 arylalkyl or phenyl; and the other of R1 and R2 is a group of the formula
 -COOR14
 wherein R14 is hydrogen, an organic or inorganic cation, a carboxy-protecting group or a non-toxic, metabolically-labile ester forming group; and
 R3 and R4 are the same or different and are hydrogen, C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl or a group of the formula
 -COOR15
 wherein R15 has the same definition as R9;
 R5 and R6 are:
 1) each hydrogen, an amino protecting group; or acyl group derived from a C1 to C30 carboxylic acid;
 provided that at least one of R5 and R6 must be hydrogen; or
 2) taken together to form a phthalimido group;
 or a pharmaceutically-acceptable salt thereof.
Patent IL-96687-A0 (IL)
Title: Continuous production of films of ordered poly(aryl ether ketone ketones)
IPC: B29D7/01
Filed: 1990-12-17
Abstract: A process for extruding a smooth and uniform film or sheet of an ordered poly(ether ketone ketone) having a thickness of about 2.5 to 250 micrometers, wherein the molten extrudate is quenched on a drum maintained at a temperature of about 100-170 DEG C. <IMAGE>
Patent IL-96772-A0 (IL)
Title: Internally damped thin-walled,composite longitudinal member having dedicated internal constraining layers
IPC: B64G99/00
Filed: 1990-12-24
Abstract: An internally damped structure having a thin, segmented layer (10) of high modulus composite material acting as a constraining layer & bonded on both sides to layers of viscoelastic damping material (8) acting as shear layers. The arrangement forms a triple layer sandwich which is embedded in the wall of the structure. A compliant filler (12) is positioned between adjacent segments of the composite constraining layer. In an alternate embodiment, two such sandwich arrangements are embedded in the wall of the structure.
Patent IL-106968-A0 (IL)
Title: Potentiation of immunogenic response
IPC: A61P37/04
Filed: 1993-09-10
Abstract: An immunogen for eliciting an immune response to antigens, particularly normally weakly-immunogenic viral antigens, such as the haemagglutinin antigen (HA) from influenza virus contains the antigen in two different physio-chemical forms. The immunogen may comprise one composition containing the two antigen forms or there may be two compositions containing respective antigen forms. Administration of the immunogen to an animal at one or more sites gives an enhanced immune response compared to the immunogen comprising only one of the two antigen forms.
Patent IL-109531-A0 (IL)
Title: A vehicle having an electric and mechanical braking system
IPC: B60L7/24
Filed: 1994-05-03
Abstract: The present invention relates to a vehicle (31) comprising a mixed (electrical and mechanical) braking system. This mixed braking system comprises asynchronous electric motors (4a to 4d) associated with the wheels (2a to 2d) and a mechanical braking system including a hydraulic circuit (14) and mechanical brakes (18a to 18d). In addition, the mixed braking system comprises measurement electronics (36) connected to rotational frequency sensors (34a to 34d) placed on each of the wheels, these electronics providing a reference signal for means (6) for controlling the asynchronous electric motors, which means adjust the stator frequency of these motors as a function of the value of the reference signal. The braking system according to the invention is anti-lock and is very efficient in any driving situation. <IMAGE>
Patent IL-124952-A0 (IL)
Title: Method for the production of rdspa alpha1 pharmaceutical compositions containing the same and use thereof
IPC: A61K38/49
Filed: 1997-01-31
Abstract: rDSPA  alpha 1 is produced in commercial quantities and a purity adequate for clinical standards. The production methods utilize a series of chromatographic steps: cation exchange chromatography, followed by hydrophobic interaction chromatography, and ending with affinity chromatography.
Patent IL-130008-A0 (IL)
Title: Method for measurement of skin histology
IPC: A61B5/103
Filed: 1997-11-19
Abstract: A method and apparatus for non-invasively measuring skin structure. Infrared radiation over an area of skin under investigation is measured to give an indication of the variation in papillary dermis thickness over said area, and the skin color coordinates at a plurality of locations over the same area of skin is also measured. The data obtained is used to calculate corrected skin color coordinates over the area corresponding to a predetermined papillary dermis thickness. The corrected skin color coordinates so obtained are compared with a reference color coordinate range for healthy skin of the same predetermined papillary dermis thickness. At an abnormal region, where the corrected skin color coordinates lie outside the reference color coordinate range, the depth of penetration of dermal melanin can be measured.
Patent IL-130872-A0 (IL)
Title: Device for the controlled release of active compounds in the gastrointestinal tract containing an expandable component
IPC: A61K9/52
Filed: 1998-01-09
Abstract: The present invention describes a device for the controlled release of active compounds in the gastrointestinal tract with delayed pyloric passage, having a component expandable on contact with gastric juice, which is surrounded by a polymer covering which is permeable to gastric juice and active compounds. The device contains at least one active compound which is present in a multiparticulate preparation which releases the active compound into the gastric juice with a delay. Compared with conventional pharmaceutical forms with delayed pyloric passage, the release of active compound from a device according to the invention can be better controlled; likewise the device can be easily rolled or folded and can be introduced into capsules without problems.
Patent IL-141092-A0 (IL)
Title: Exactly divisible tablet
IPC: A61J3/10
Filed: 1999-08-11
Abstract: The invention describes a tablet with two end faces and a circumferential face, in which the mutually opposite end faces of the tableta) overall are nonplanar and are arranged at least approximately parallel to one another, andb) are each provided with a score on the top and bottom sides, the scores lying in the center of the tablet parallel to and above one another.
Patent IL-146257-A0 (IL)
Title: Method of producing methoxyimido acetic amide
IPC: C07C67/20
Filed: 2000-05-12
Abstract: The present invention relates to novel processes for preparing methoxyimino-acetamides.
Patent IL-150350-A0 (IL)
Title: New modulators of dopamine neurotransmission
IPC: C07D295/096
Filed: 2000-12-22
Abstract: New substituted 4-(phenyl-N-alkyl)-piperidine compounds of Formula 1: <CHEM> wherein X is CH; R1 is CF3, OSO2CF3, OSO2CH3, SOR7, SO2R7, COR7, CN, OR3, NO2, CONHR3, 3-thiophene, 2-thiophene, 3-furane, 2-furane, F, Cl, Br, or I; R2 is F, Cl, Br, I, CN, CF3, CH3, OCH3, OH, and NH2; R3 and R4 are H; R5 is a C1-C4 alkyl, an allyl, CH2SCH3, CH2CH2OCH3, CH2CH2CH2F, CH2CF3, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, or -(CH2)-R6; R6 is a C3-C6 cycloalkyl, 2-tetrahydrofurane, or 3-tetrahydrofurane; R7 is a C1-C3 alkyl, CF3, or N(R4)2, and pharmaceutically acceptable salts thereof are disclosed. <??>Also pharmaceutical compositions comprising the above compounds and methods wherein the above compounds are used for treatment of disorders in the central nervous system are disclosed.